UNSPSC 51393107: Guanoxabenz hydrochloride

This classification denotes an alpha-adrenergic agonist with the molecular formula C8H8Cl2N4O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ASL1V61E48, chemically known as hydrazinecarboximidamide, 2-((2,6-dichlorophenyl)methylene)-n-hydroxy-, hydrochloride (1:1), but more generally known as guanoxabenz hydrochloride, which bears US NIH Compound Identifier 17750940.

European Medicines Agency schedules guanoxabenz hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14038MIG. Most nations, for tariff purposes, schedule guanoxabenz hydrochloride under HS 29280090. SMILES: C1CC(C(C(C1)CL)/C=N/NC(=N)NO)CL.CL.

UNSPSC 51393107 Guanoxabenz hydrochloride is a Commodity code that in practice shows little alignment between the code's nominal scope and recent state and local procurement activity. The two recent opportunities posted under this code—Seminole County's procurement of naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's RFI for direct-to-manufacturer pharmacy programs—do not address guanoxabenz hydrochloride or closely related pharmaceutical products. The Seminole County IFB, posted June 30, 2026, explicitly solicits naloxone and safe drug deactivation systems through competitive sealed bidding with quarterly deliveries to a community health building. The Texas HHS RFI, posted April 3, 2026, seeks vendor capabilities for establishing direct relationships between the state's pharmacy benefit program and pharmaceutical manufacturers to improve prescription fulfillment efficiency, focusing on self-insured employer and health plan contracting outside traditional pharmacy benefit manager and group purchasing organization channels. Neither opportunity targets the specific active pharmaceutical ingredient this code nominally describes.

The geographic activity shown in recent postings spans Florida and Texas, with issuing bodies including a county government and a state health agency. The Seminole County opportunity carries a fixed-fee structure with a two-year initial term and one-year renewal option, subject to a three-month probationary period and potential FEMA compliance requirements. The Texas RFI functions as exploratory market intelligence rather than a binding solicitation, with no award value, budget range, or evaluation criteria specified. The mismatch between the code's name and the work actually being solicited suggests either a tagging error or a code that state and local procurement offices are applying to pharmaceutical procurement broadly rather than to guanoxabenz hydrochloride specifically.